Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT01119859

Public ClinicalTrials.gov record NCT01119859. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Blinded, Parallel-group Study of the Reduction of Signs and Symptoms During Monotherapy Treatment With Tocilizumab 8 mg/kg Intravenously Versus Adalimumab 40 mg Subcutaneously in Patients With Rheumatoid Arthritis

Study identification

NCT ID
NCT01119859
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
326 participants

Conditions and interventions

Interventions

  • Tocilizumab Drug
  • Adalimumab Drug
  • Placebo to tocilizumab Drug
  • Placebo to adalimumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Feb 10, 2013

2010 – 2012

United States locations

U.S. sites
33
U.S. states
21
U.S. cities
33
Facility City State ZIP Site status
Not listed Anniston Alabama 36207
Not listed Birmingham Alabama 35294
Not listed Scottsdale Arizona 85258
Not listed Hot Springs Arkansas 71913
Not listed Little Rock Arkansas 72205
Not listed San Diego California 92108
Not listed Colorado Springs Colorado 80910
Not listed Trumbull Connecticut 06611
Not listed Boca Raton Florida 33486
Not listed Fort Lauderdale Florida 33334
Not listed Ormond Beach Florida 32174
Not listed Idaho Falls Idaho 83404
Not listed Springfield Illinois 62704
Not listed Cumberland Maryland 21502
Not listed Flowood Mississippi 39232
Not listed Tupelo Mississippi 38802
Not listed Lincoln Nebraska 68516
Not listed Dover New Hampshire 03820
Not listed New Brunswick New Jersey 08903
Not listed Hickory North Carolina 28601
Not listed Dayton Ohio 45402
Not listed Duncansville Pennsylvania 16635
Not listed Willow Grove Pennsylvania 19090
Not listed Wyomissing Pennsylvania 19610
Not listed Greenville South Carolina 29601
Not listed Hixson Tennessee 37343
Not listed Houston Texas 77074
Not listed Lubbock Texas 79424
Not listed Mesquite Texas 75150
Not listed Nassau Bay Texas 77058
Not listed Waco Texas 76708
Not listed Spokane Washington 99204
Not listed Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01119859, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01119859 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →